...CD137 mAb show therapeutic synergy against B16-OVA melanoma.
Activated OT-1 cells and systemic injection of anti-CD137 mAb show therapeutic synergy against B16-OVA melanoma.Francesco PappalardoIvan Martinez ForeroMarzio PennisiAsis PalazonIgnacio MeleroSanto Motta